The aim of serialisation is to affix a unique identifier to each box of medicinal products. This obligation aims to reinforce the identification of each product unit so as to combat counterfeiting and reduce public health risks related to fraud as much as possible.
With its partners, Digital CSP offers a range of flexible services. Capable of generating unique numbers for boxes of medicinal products in compliance with specific encoding algorithms, Digital CSP can take into account the specifications of every sub-contracting toller and adapt data interchange with the appropriate safety and level of encoding. Digital CSP acts as a trusted intermediary between the manufacturers, their pharmaceutical laboratory contract givers and the centralising authorities for serialisation.
Digital CSP also provides digital solutions for a much higher level of safety and access to digital data by using latest generation electronic tags.
Serialisation is a regulatory requirement that calls for major industrial investment along with considerable data flow. Just when e-commerce is starting to grow on the healthcare products market, on a global marketplace where trade is getting easier and easier, serialisation has become a major opportunity for manufacturers.
Serialisation also helps to identify each product unit at its place of delivery or destruction. Each unique unit can be linked to a healthcare professional or a user. The medical care chain is getting organised so as to be able to monitor each unit when it passes through each of the key stages of the logistics chain, from production through to dispensing and all the various phases of the supply chain.
Newsletter DIGITAL CSP: